Uncategorized EastGate Biotech Announces Preparation to Initiate Phase III Clinical Trials on Insugin, its Liquid Insulin Mouth Rinse for Type 2 diabetes patients March 9, 2022 Posted by admin 09 Mar
admin
(+035) 527-1710-70